Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2016 Earnings

2NovConfirmed

Q1 2016

Q2 2016

Q3 2016

Q4 2016

-4.27

-3.96

-3.65

-3.34

Details

Expected EPS

-3.6741384999999998

Actual EPS

-3.9342545

Surprise EPS

-0.26

Surprise Percent

+7.08%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.9342545 per share for Q4 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.